Clinical trial
A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics…
NCT00453479 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00453479 |
|---|---|
| Title | A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. |
| Official title | A Randomised, Double-blind, Placebo-controlled, Dose Ascending, 2-cohort, Parallel Group Study to Examine the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Twice-daily Inhaled Doses of GSK233705B Formulated With the Excipient Magnesium Stearate in COPD Subjects for 7-days. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK233705B |
| Enrollment | 23 |
| Start date | Mar 28, 2007 |
| Primary completion | Oct 11, 2007 |
| Completion | Oct 11, 2007 |
| First posted | Mar 29, 2007 |
| Last update posted | Mar 12, 2018 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: